CustomerValidation
- •CancerRes.2016Nov15;76(22):6631-6642.
- •JAutoimmun.2017Jun;80:28-38.
- •BrainBehavImmun.2017Jan;59:322-332.
- •BasicResCardiol.2017Jan;112(1):9.
- •Oncotarget.2017May9;8(19):31802-31814.
- •Oncotarget.2017May2;8(18):29996-30007.
- •Oncotarget.2017Mar28;8(13):21044-21053.
- •CellPhysiolBiochem.2017Mar29;41(4):1675-1683.
- •SciRep.2017Mar8;7:43834.
- •SciRep.2017Mar8;7:43796.
- •SciRep.2016Aug4;6:30957.
- •SciRep.2016Jun9;6:27866.
- •JNeuRochem.2017Oct;143(2):225-235.
- •JNeurochem.2016May;137(4):576-88.
- •ExpCellRes.2015Feb15;331(2):320-30.
- •MolPain.2014Feb6;10(1):10.
- •AmJPhysiolGastrointestLiverPhysiol.2016Dec1;311(6):G1091-G1104.
- •AmJPhysiolGastrointestLiverPhysiol.2014Feb;306(3):G244-52.
- •Neuroscience.2017Sep30;360:128-138.
- •FoodFunct.2017May24;8(5):1905-1914.
- •Vaccine.2017Feb15;35(7):1037-1045.
- •Vaccine.2015Apr15;33(16):1923-33.
- •LifeSci.2017Feb1;170:25-32.
- •Molecules.2017Jul15;22(7).pii:E1187.
- •PLoSOne.2017Jul24;12(7):e0181796.
- •PLoSOne.2017May24;12(5):e0178147.
- •OncolRep.2017Jun;37(6):3341-3350.
- •VetMicrobiol.2017May;203:158-166.
- •JSciFoodAgric.2017Nov;97(14):4727-4736.
- •PhotochemPhotobiol.2016Nov;92(6):816-825.
- •JBiochem.2017Oct18.
- •Cytotechnology.2017Apr;69(2):229-244.
- •BMCMusculoskeletDisord.2014Jan15;15(1):18.
- •MolMedRep.2017Sep;16(3):3111-3116.
- •OncolLett.2016Aug;12(2):1034-1040.
- •BiosciBiotechnolBiochem.2016Jul;80(7):1393-402.
- •ChinMedJ(Engl).2017Apr20;130(8):906-913.
- •UniversityofArizona.02-Nov-2017.
- •BiochemBiophysRep.2017Sep;11:147-153.
- •HainanMedJ,Aug.2017,Vol.28,No.15.
- •ChineseJournalofPublicHealth.2016,32(11):1480-1484.
- •UniversitätWürzburg.2016.
- •SeitokuUniversity.2014.
Description | TAK-242isapotentTLR4signalinginhibitor,selectivelyinhibitstheTLR4-mediatedproductionofcytokinesandNO. |
---|---|
IC50&Target | TLR4[1] |
InVitro | InRAW264.7cellsandmouseperitonealmacrophages,TAK-242suppresseslipopolysaccharide(LPS)-inducedproductionofNO,tumornecrosisfactor-α(TNF-α),andinterleukin(IL)-6,withIC50of1.1to11nM.TAK-242alsosuppressestheproductionofthesecytokinesfromLPS-stimulatedhumanperipheralbloodmononuclearcells(PBMCs)atIC50valuesfrom11to33nM[1]. |
InVivo | TAK-242apparentlyreducestheserumanti-dsDNAlevelsinbothgenotypemice.Alternatively,IFN-γ,TNF-α,andIL-1βproductionismarkedlyinhibitedbyTAK-242,buttheirconcentrationsarestillgreatlyhigherthanthoseinNS-treatedcounterparts[2].TAK-242pre-stressadmiNISTrationpreventstheaccumulationofpotentiallydeleteriousinflammatoryandoxidative/nitrosativemediatorsinthebrainfrontalcortexofrats.TAK-242i.v.administrationatthebeginningofthestresssessioncompletelyblocksTLR-4mRNAandproteinupregulationafterstressexposure[3]. |
ClinicalTrial | ViewMoreCollapse |
References |
|
PreparingStockSolutions |
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent. | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CellAssay [1] | TAK-242isdissolvedinN,N-dimethylformamide,andthendilutedwithappropriatemediumbeforeuse[1]. RAW264.7cellsareseededatadensityof3×106cells/wellinsix-wellcultureplateandincubatedovernight.AfterwashingwithRPMI1640mediumsupplementedwith1%FCSand10μg/mLKanamycin,thecellsarestimulatedwith5ng/mLLPSand1U/mLIFN-γinthepresenceorabsenceofTAK-242(1-100nM)fortheindicatedtime.Culturesupernatantsareremoved,andtotalRNAisisolatedusingthetotalRNAisolationreagentISOGEN.TotalRNAisreversetranscribedintoCDNAbyusingTaqManreversetranscriptionreagents.Quantitativereal-timePCRanalysisofTNF-αandIL-6isperformedonABIPrism7700usingpredevelopedTaqManassayreagentsandUniversalPCRmastermix.QuantitationofmRNAisperformedusingthecomparativethresholdcyclemethod.Thehighestcontrollevelattainedbythestimulation(withoutTAK-242)isregardedas100%,andthelevelsofcontrolgroupatothertimepointsandTAK-242-addedgroupareexpressedasthepercentageofthehighestcontrollevel[1].MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly. | ||||||||||||||||
AnimalAdministration [2][3] | TAK-242isdissolvedinvehicle(saline)(Mice)[2]. Mice[2] | ||||||||||||||||
References |
|
MolecularWeight | 361.82 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Formula | C₁₅H₁₇ClFNO₄S | ||||||||||||
CASNo. | 243984-11-4 | ||||||||||||
Storage |
| ||||||||||||
Shipping | RoomtemperatureincontinentalUS;mayvaryelsewhere | ||||||||||||
Solvent&Solubility | DMSO:≥360mg/mL TAK-242isdissolvedinafatemulsion(i.v.injection)[4]. *"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">1> | ||||||||||||
References |
|
Purity:99.95%ee.:98.00%
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
就是蛋白质分子的小片断
是氨基酸形成的
一、首先你要明白肽是什么...........................肽是氨基酸通过酰胺键结合而成的东西.........
二、你要明白氨基酸是什么..........................氨基酸是构成蛋白质的基本单位,多种氨基酸结合为长肽链,几条长肽链再盘旋就形成了蛋白质......................
三、关于小分子肽、短肽、多肽、寡肽.......其实都是肽.......区别只是由多少个氨基酸构成而已............
所以,你的问题可以很粗暴地理解为“蛋白质对人体有没有副作用”.......
如果你营养足够的情况下,再补充这个,会导致营养过剩,从而加重身体代谢的负荷............类似就是这样子的了...........小分子肽,一般现在用于化妆品上比较多(一ye子.植物肽面膜就是这个).......小分子肽(可以简单理解为纳米胶原蛋白),这比蛋白质(也可以粗暴理解为胶原蛋白)更加容易吸收......而用在食品上,要视乎是何种小分子肽了.....大豆肽、花生肽、大米肽....不同的肽有不同的功效.......主要可以改善风味、改善吸收、增强胃肠道功能等等.......
求助各位前辈,我最近在合成的化合物水溶性很好,非常好,以至于可以随便溶解在水里,它的六氟磷酸盐也可以随意溶解在水里(大于50uM),细胞成像实验显示它根本进不去细胞,求问有没有啥方法包裹一下让它进去?我搜了一下文献,感觉多数是把脂溶性特别好的东西包裹一下弄进去的,也许是搜索姿势不对没找到我需要的答案,**点拨啊!!!